Cargando…
Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation
Background: Cytomegalovirus (CMV) reactivation is a common complication in patients undergoing allogeneic stem cell transplantation. However, the incidence of CMV reactivation is low after autologous stem cell transplantation (auto-SCT), and the prognostic value of CMV reactivation remains controver...
Autores principales: | Lee, Byung-Hyun, Jeon, Min Ji, Yu, Eun Sang, Kang, Ka-Won, Kim, Dae Sik, Lee, Se Ryeon, Park, Yong, Sung, Hwa Jung, Choi, Chul Won, Kim, Byung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925986/ https://www.ncbi.nlm.nih.gov/pubmed/36794152 http://dx.doi.org/10.7150/ijms.79285 |
Ejemplares similares
-
Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea
por: Kang, Ka-Won, et al.
Publicado: (2023) -
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017) -
Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
por: Lee, Se Ryeon, et al.
Publicado: (2010) -
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
por: Lee, Byung-Hyun, et al.
Publicado: (2020) -
Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
por: Kang, Ka‐Won, et al.
Publicado: (2020)